Involvement of prostacyclin and potassium channels in the diabetes-induced hyporeactivity of the rabbit carotid artery to B-type natriuretic peptide.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Miranda L
Grupos
Abstract
The relation between diabetes and stroke is bidirectional: diabetes is an important risk factor for ischemic stroke, and acute stroke frequently induces hyperglycemia. On the other hand, plasma B-type natriuretic peptide (BNP) levels are raised in diabetes and stroke. The purpose was to study how alloxan-induced diabetes might modify the effects of BNP in rabbit carotid arteries and the mechanisms involved in such actions. To do this, isometric tension in isolated rabbit carotid artery was recorded and prostanoids release and plasma NT-proBNP were measured by enzyme immunoassay. BNP induced a relaxation of phenylephrine-precontracted carotid arteries, and this relaxation was lower in diabetic than in control rabbits. Endothelium removal did not modify the relaxation to BNP in control rabbits but increased this relaxation in diabetic rabbits. In control rabbits, indomethacin inhibited the BNP-induced relaxation in the presence and in the absence of endothelium. In diabetic rabbits, indomethacin did not modify the BNP-induced relaxation in arteries with endothelium and inhibited it in arteries without endothelium. In the presence of BNP the carotid artery released thromboxane A2 and prostacyclin, and the release of endothelial prostacyclin was inhibited in diabetic rabbits. Glibenclamide and 4-aminopyridine inhibited the relaxation to BNP, and these inhibitions were lower in diabetic than in control rabbits. In conclusion, our results provide a new understanding concerning the mechanisms of the diabetes-induced hyporeactivity of the carotid artery to BNP, that at least include the loss of endothelial prostacyclin and a reduced participation of ATP-sensitive K(+) channels (KATP) and voltage-sensitive K(+) channels (KV).
Datos de la publicación
- ISSN/ISSNe:
- 0014-2999, 1879-0712
- Tipo:
- Article
- Páginas:
- 159-167
- PubMed:
- 23340222
- Factor de Impacto:
- 1,068 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
EUROPEAN JOURNAL OF PHARMACOLOGY ELSEVIER SCIENCE BV
Citas Recibidas en Web of Science: 5
Documentos
- No hay documentos
Filiaciones
Proyectos y Estudios Clínicos
INVESTIGACION EN RED DE LAS ENFERMEDADES NEUROLOGICAS
Investigador Principal: JUAN JESÚS VÍLCHEZ PADILLA
C03/06 . INSTITUTO DE SALUD CARLOS III . 2003
RED DE INVESTIGACION (RENEVAS)
Investigador Principal: ENRIQUE ALBORCH DOMÍNGUEZ
RD06/0026/0006 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA (FIDIS); FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2006
RED DE INNOVACION EN TECNOLOGIAS MEDICAS Y SANITARIAS - RED ITEMAS
Investigador Principal: JOSÉ VICENTE CASTELL RIPOLL
RD09/0077/00156 . INSTITUTO DE SALUD CARLOS III . 2010
MICROCLUSTERS-CALIDAD, SEGURIDAD Y FUNCIONALIDAD DE ALIMENTOS
Investigador Principal: JOSÉ LUIS MULLOR SANJOSÉ
2011_0171_VLC/CAMPUS_MCI_MULLOR_SALOM . 2011
INFLUENCIA DE LA DIABETES SOBRE LAS VIAS DE SEÑALIZACION DE LOS RECEPTORES ESTROGENICOS CEREBRALES EN EL ICTUS ISQUEMICO AGUDO EXPERIMENTAL: IMPLICACIONES TERAPEUTICAS
Investigador Principal: GERMÁN TORREGROSA BERNABÉ
PI12/00145 . INSTITUTO DE SALUD CARLOS III . 2013
ENFERMEDADES VASCULARES CEREBRALES (ICTUS)
Investigador Principal: JUAN BAUTISTA SALOM SANVALERO
RD12/0014/0004 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013